Laura Niklason

CEO

Board Member

Equibles does not estimate personal net worth.

Get an email with a short summary when Humacyte, Inc. publishes a filing, an earnings call transcript or a press release.

Get HUMA alerts

About Laura Niklason

Laura Niklason is recorded as Board Member at Humacyte, Inc. (HUMA) since January 1, 2021 and CEO at Humacyte, Inc. (HUMA). The proxy statement of Humacyte, Inc. reports total compensation of $5,234,908 for Laura Niklason in fiscal 2025, including a base salary of $633,606. Disclosed compensation is on record for 6 fiscal years. Laura Niklason has spoken on 19 earnings calls across 1 company, most recently for Humacyte, Inc. on November 10, 2026. Humacyte, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Humacyte, Inc. includes Laura E. Niklason (CEO and Board Member), Dale A. Sander (CFO), Dale Sander (CFO) and 7 others.

Laura Niklason on recent calls

“Thank you, Tom, and good morning, everyone, and I want to thank you for joining us for our third quarter financial results and business update call. I would like to, I could not be more excited to share the progress that we're making at HumaSight.”

CEO, Humacyte Third Quarter 2026 Financial Results and Corporate Update · November 10, 2026

“And thank you for joining us for our first quarter financial results and business update call for 2026.”

CEO, Humacyte, Inc. Q1 FY2026 Earnings Call · May 13, 2026

“Good morning, everyone, and thank you for joining us for a 2025 fourth quarter and year financial results and business update call.”

CEO, Humacyte, Inc. Q4 FY2025 Earnings Call · March 27, 2026

“Good morning, everyone, and thank you for joining us for our third quarter 2025 financial results and business update call.”

CEO, Humacyte, Inc. Q3 FY2025 Earnings Call · November 12, 2025

“Thank you, Tom, and good morning, everyone, and thank you for joining us for our second quarter 2025 financial results and business update call.”

CEO, Humacyte, Inc. Q2 FY2025 Earnings Call · August 11, 2025

Affiliation history

Humacyte, Inc. (HUMA)
Board Member

Proxy statement

Current
2021-01-01–present
Humacyte, Inc. (HUMA)
CEO

Proxy statement

Current

Company network

Humacyte, Inc.

HUMA

Current role

Biotechnology · Healthcare

CEO, Board Member

2021-01-01–present

19 appearances Latest appearance 2026-11-10

View calls and events

Leadership on record at Humacyte, Inc.

Laura E. Niklason CEO, Board Member
Dale A. Sander CFO
Dale Sander CFO
Heather Prichard COO
Brady W. Dougan Board Member
C. Bruce Green Board Member
Diane Seimetz Board Member
Emery N. Brown Board Member
John P. Bamforth Board Member
Kathleen Sebelius Board Member

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Humacyte, Inc. (HUMA)	President and Chief Executive Officer	$633,606	$253,983	—	$4,332,725	—	$14,594	$5,234,908
2024	Humacyte, Inc. (HUMA)	President and Chief Executive Officer	$612,400	$278,642	—	—	—	$14,394	$905,436
2023	Humacyte, Inc. (HUMA)	President and Chief Executive Officer	$603,754	$281,704	—	$1,726,450	—	$13,794	$2,625,702
2022	Humacyte, Inc. (HUMA)	President and Chief Executive Officer	$500,000	$212,500	—	$1,031,240	—	$5,348	$1,749,088
2021	Humacyte, Inc. (HUMA)	President and Chief Executive Officer	$500,000	$237,500	—	$10,021,428	—	$44,168	$10,803,096
2020	Humacyte, Inc. (HUMA)	President and Chief Executive Officer	$75,000	—	—	$20,006	—	$106,277	$201,283

Recent activity

Earnings call Humacyte Third Quarter 2026 Financial Results and Corporate Update Humacyte, Inc. (HUMA)
2026-11-10
Earnings call Humacyte, Inc. Q1 FY2026 Earnings Call Humacyte, Inc. (HUMA)
2026-05-13
Earnings call Humacyte, Inc. Q4 FY2025 Earnings Call Humacyte, Inc. (HUMA)
2026-03-27
Earnings call Humacyte, Inc. Q3 FY2025 Earnings Call Humacyte, Inc. (HUMA)
2025-11-12
Earnings call Humacyte, Inc. Q2 FY2025 Earnings Call Humacyte, Inc. (HUMA)
2025-08-11
Earnings call Humacyte, Inc. Q1 FY2025 Earnings Call Humacyte, Inc. (HUMA)
2025-05-13
Earnings call Humacyte, Inc. Q4 FY2024 Earnings Call Humacyte, Inc. (HUMA)
2025-03-28
Earnings call Humacyte, Inc. Q3 FY2024 Earnings Call Humacyte, Inc. (HUMA)
2024-11-08
Earnings call Humacyte, Inc. Q2 FY2024 Earnings Call Humacyte, Inc. (HUMA)
2024-08-13
Earnings call Humacyte, Inc. Q1 FY2024 Earnings Call Humacyte, Inc. (HUMA)
2024-05-10
Earnings call Humacyte, Inc. Q4 FY2023 Earnings Call Humacyte, Inc. (HUMA)
2024-03-22
Earnings call Humacyte, Inc. Q3 FY2023 Earnings Call Humacyte, Inc. (HUMA)
2023-11-09

Show 7 earlier activities

Earnings call Humacyte, Inc. Q2 FY2023 Earnings Call Humacyte, Inc. (HUMA)
2023-08-14
Earnings call Humacyte, Inc. Q1 FY2023 Earnings Call Humacyte, Inc. (HUMA)
2023-05-12
Earnings call Humacyte, Inc. Q4 FY2022 Earnings Call Humacyte, Inc. (HUMA)
2023-03-24
Earnings call Humacyte, Inc. Q3 FY2022 Earnings Call Humacyte, Inc. (HUMA)
2022-11-10
Earnings call Humacyte, Inc. Q2 FY2022 Earnings Call Humacyte, Inc. (HUMA)
2022-08-12
Earnings call Humacyte, Inc. Q1 FY2022 Earnings Call Humacyte, Inc. (HUMA)
2022-05-13
Earnings call Humacyte, Inc. Q4 FY2021 Earnings Call Humacyte, Inc. (HUMA)
2022-03-29